fda statement on compounded semaglutide is not the same as FDA-approved. The has documented dosing errors and hospitalizations linked to these products. Dr. Jen Ashton breaks down the risks. Always consult your physician before Novo asks FDA to prevent
Description
402:693-704 [PubMed: 37385279] 380

Retatrutide represents the next evolution in this space and while it is not yet widely available, Inner Glow is among the select providers offering it under professional supervision

doi:10.1242/jeb.00861

The Tip of an Emerging Iceberg Whats happening now with GLP-1s is an important glimpse of what lies ahead
